Mahajan Janhavi, Varma Anuj, Kumar Sunil, Acharya Sourya, Shukla Samarth, Kothari Manjeet, Gemnani Rinkle
Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharastra, India.
Department of Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharastra, India.
J Family Med Prim Care. 2025 Feb;14(2):743-748. doi: 10.4103/jfmpc.jfmpc_1579_24. Epub 2025 Feb 21.
A glucose homeostasis condition known as insulin resistance (IR) is characterized by a decreased sensitivity of adipose tissue, muscle fiber, liver, and other bodily tissues to insulin, even in the presence of normal or elevated blood concentrations of the hormone. Nevertheless, it is uncommon to evaluate the comorbidity of insulin resistance and thyroid discrepancies, particularly the order in which these indicators appear. This study emphasizes the association between hypothyroidism and insulin resistance.
Eighty individuals with suspected thyroid illness or related problems were recruited for this cross-sectional study at the AVBR Hospital in Wardha between December 2020 and September 2022. The participants were categorized as having subclinical hypothyroidism, overt hypothyroidism, or controls based on the thyroid indicators detected in their serum. The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was used to perform the calculations. A Chi-square test was used in addition to control to examine the relationship between insulin resistance and thyroid function. Results are considered statistically significant only if the value is less than 0.05.
Levels of HOMA-IR were lowest in the Controls (1.65), followed by the Subclinical Group (2.03), and highest in the Overt Group (5.00). HOMA-IR had a significant positive relationship with thyroid stimulating hormone, fasting insulin, and fasting blood sugar (FBS). The prevalence of insulin resistance was 64.3% in overt hypothyroid patients and 36% in subclinical hypothyroid patients. In contrast, it was 21% in the control group of hypothyroid patients on thyroxine therapy for over two months.
Thyroid levels and the IR were significantly correlated. The prevalence of insulin resistance was 64.3% in overt hypothyroid and 36% in subclinical hypothyroid in this part of rural area. Therefore having awareness at the primary care physician level may prevent its morbid complications even assessed.
一种被称为胰岛素抵抗(IR)的葡萄糖稳态状况,其特征是即使在血液中该激素浓度正常或升高的情况下,脂肪组织、肌纤维、肝脏及其他身体组织对胰岛素的敏感性降低。然而,评估胰岛素抵抗与甲状腺异常的合并症,尤其是这些指标出现的顺序并不常见。本研究强调甲状腺功能减退与胰岛素抵抗之间的关联。
2020年12月至2022年9月期间,在沃尔哈的AVBR医院招募了80名疑似患有甲状腺疾病或相关问题的个体进行这项横断面研究。根据血清中检测到的甲状腺指标,将参与者分为亚临床甲状腺功能减退、显性甲状腺功能减退或对照组。使用胰岛素抵抗稳态模型评估(HOMA-IR)进行计算。除了对照外,还使用卡方检验来研究胰岛素抵抗与甲状腺功能之间的关系。仅当P值小于0.05时,结果才被认为具有统计学意义。
对照组的HOMA-IR水平最低(1.65),其次是亚临床组(2.03),显性组最高(5.00)。HOMA-IR与促甲状腺激素、空腹胰岛素和空腹血糖(FBS)呈显著正相关。显性甲状腺功能减退患者的胰岛素抵抗患病率为64.3%,亚临床甲状腺功能减退患者为36%。相比之下,接受甲状腺素治疗超过两个月的甲状腺功能减退对照组患者的患病率为21%。
甲状腺水平与胰岛素抵抗显著相关。在该农村地区的这部分人群中,显性甲状腺功能减退患者的胰岛素抵抗患病率为64.3%,亚临床甲状腺功能减退患者为36%。因此,即使在基层医疗医生层面提高认识,也可能预防其发病并发症。